Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Armen Panossian J.D. | CEO & Chief Investment Officer | -- | -- | 1976 |
| Mr. Mathew M. Pendo | President | -- | -- | 1964 |
| Dr. Aman Kumar M.D. | Managing Director & Co-Portfolio Manager of Life Sciences Direct Lending | -- | -- | 1980 |
| Mr. Raghav Khanna | Managing Director & Co-Portfolio Manager | -- | -- | 1984 |
| Mr. Christopher McKown | MD,CFO & Treasurer | -- | -- | 1982 |
| Mr. Michael Mosticchio | Investor Relations | -- | -- | -- |
| Ms. Mary Gallegly J.D. | MD,General Counsel & Secretary | -- | -- | -- |
| Ms. Ashley Pak | Chief Compliance Officer | -- | -- | 1978 |
| Mr. Sandeep Kumar Khorana | Managing Director of Origination | -- | -- | 1973 |
| Ms. Lucia S. Kim | Senior Vice President | -- | -- | -- |
Oaktree Specialty Lending Corporation
- Sector:
- Financial Services
- Industry: Asset Management
Description
Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering. The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies. The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.
Corporate Governance
Upcoming Events
December 31, 2024 at 12:00 AM UTC
Dividend Date
January 30, 2025 at 1:30 PM UTC - February 3, 2025 at 1:30 PM UTC
Oaktree Specialty Lending Corporation Earnings Date
Recent Events
October 28, 2024 at 12:00 AM UTC
40-17G: Fidelity bond filed pursuant to Rule 17g1(g)(1) of the Investment Company Act of 1940
September 16, 2024 at 12:00 AM UTC
Ex-Dividend Date
May 17, 2024 at 12:00 AM UTC
40-APP/A: Applications under the Investment Company Act other than those reviewed by Office of Insurance Products
May 15, 2024 at 12:00 AM UTC
40-APP/A: Applications under the Investment Company Act other than those reviewed by Office of Insurance Products